Abstract |
|
Authors | Andreas Viardot, Franco Locatelli, Julia Stieglmaier, Faraz Zaman, Elias Jabbour |
Journal | Annals of hematology
(Ann Hematol)
Vol. 99
Issue 10
Pg. 2215-2229
(Oct 2020)
ISSN: 1432-0584 [Electronic] Germany |
PMID | 32856140
(Publication Type: Journal Article, Review)
|
Chemical References |
- Adrenal Cortex Hormones
- Antibodies, Bispecific
- Antigens, CD19
- Antigens, Neoplasm
- Antineoplastic Agents, Immunological
- CD19 molecule, human
- blinatumomab
|
Topics |
- Adolescent
- Adrenal Cortex Hormones
(therapeutic use)
- Adult
- Antibodies, Bispecific
(administration & dosage, adverse effects, economics, therapeutic use)
- Antigens, CD19
(immunology)
- Antigens, Neoplasm
(immunology)
- Antineoplastic Agents, Immunological
(administration & dosage, adverse effects, economics, therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- B-Lymphocyte Subsets
(immunology)
- Child
- Clinical Trials as Topic
- Combined Modality Therapy
- Cost-Benefit Analysis
- Cytokine Release Syndrome
(etiology, prevention & control)
- Drug Costs
- Humans
- Immunotherapy, Adoptive
(adverse effects, economics)
- Infusions, Intravenous
- Injections, Subcutaneous
- Lymphoma, B-Cell
(drug therapy, immunology, therapy)
- Neoplasm, Residual
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
(drug therapy, immunology, pathology, therapy)
- Premedication
- Quality of Life
- T-Lymphocyte Subsets
(immunology)
- Treatment Outcome
- Tumor Burden
- Tumor Escape
|